These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37214540)

  • 21. Identification of parkinsonism and Parkinson's disease.
    Camicioli R
    Drugs Today (Barc); 2002 Oct; 38(10):677-86. PubMed ID: 12582453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parkinsonism and tremor syndromes.
    Bellows S; Jankovic J
    J Neurol Sci; 2022 Feb; 433():120018. PubMed ID: 34686357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anomalies of asymmetry of clinical signs in parkinsonism.
    Toth C; Rajput M; Rajput AH
    Mov Disord; 2004 Feb; 19(2):151-7. PubMed ID: 14978669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Iatrogenic parkinsonism: the role of flunarizine and cinnarizine.
    Miguel R; Correia AS; Bugalho P
    J Parkinsons Dis; 2014; 4(4):645-9. PubMed ID: 25125483
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Akinetic-rigid and tremor-dominant Parkinson's disease patients show different patterns of FP-CIT single photon emission computed tomography.
    Eggers C; Kahraman D; Fink GR; Schmidt M; Timmermann L
    Mov Disord; 2011 Feb; 26(3):416-23. PubMed ID: 21264942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological study.
    Schwingenschuh P; Ruge D; Edwards MJ; Terranova C; Katschnig P; Carrillo F; Silveira-Moriyama L; Schneider SA; Kägi G; Palomar FJ; Talelli P; Dickson J; Lees AJ; Quinn N; Mir P; Rothwell JC; Bhatia KP
    Mov Disord; 2010 Apr; 25(5):560-9. PubMed ID: 20131394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Valproic acid relieved marked rigidity in three patients with end-stage parkinsonism].
    Sayama S; Fujimoto K; Nakano I
    Rinsho Shinkeigaku; 1998 Jun; 38(6):495-8. PubMed ID: 9847665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DAT-SPECT imaging in cases of drug-induced parkinsonism in a specialty movement disorders practice.
    Yomtoob J; Koloms K; Bega D
    Parkinsonism Relat Disord; 2018 Aug; 53():37-41. PubMed ID: 29748111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional Role of Midbrain F-18 FP-CIT Uptake on PET in Evaluation of Essential Tremor and Parkinsonism.
    Lee H; Sung YH; Hwang KH
    Curr Med Imaging; 2023; 19(9):1041-1051. PubMed ID: 36734891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-photon emission computed tomography in diagnosis and differential diagnosis of Parkinson's disease.
    Isaias IU; Antonini A
    Neurodegener Dis; 2010; 7(5):319-29. PubMed ID: 20616566
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of DAT-SPECT in movement disorders.
    Kägi G; Bhatia KP; Tolosa E
    J Neurol Neurosurg Psychiatry; 2010 Jan; 81(1):5-12. PubMed ID: 20019219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease.
    Qamhawi Z; Towey D; Shah B; Pagano G; Seibyl J; Marek K; Borghammer P; Brooks DJ; Pavese N
    Brain; 2015 Oct; 138(Pt 10):2964-73. PubMed ID: 26209314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dopamine transporter scanning in the evaluation of patients with suspected Parkinsonism: a case-based user's guide.
    Rodriguez-Porcel F; Jamali S; Duker AP; Espay AJ
    Expert Rev Neurother; 2016; 16(1):23-9. PubMed ID: 26564057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tremor dominant parkinsonism: Clinical description and LRRK2 mutation screening.
    Clarimón J; Pagonabarraga J; Paisán-Ruíz C; Campolongo A; Pascual-Sedano B; Martí-Massó JF; Singleton AB; Kulisevsky J
    Mov Disord; 2008 Mar; 23(4):518-23. PubMed ID: 18098275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic pitfalls in Parkinson's disease: case report.
    Sekeff-Sallem FA; Barbosa ER
    Arq Neuropsiquiatr; 2007 Jun; 65(2A):348-51. PubMed ID: 17607443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Burden of non-motor symptoms in unclear parkinsonism and tremor: A study with [
    Jaakkola E; Joutsa J; Mäkinen E; Noponen T; Pitkonen M; Levo R; Mertsalmi T; Scheperjans F; Kaasinen V
    J Neurol Sci; 2019 Sep; 404():124-127. PubMed ID: 31374410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tremor and Parkinsonism in Chromosomopathies - A Systematic Review.
    Carvalho V; Ferreira JJ; Correia Guedes L
    Mov Disord; 2021 Sep; 36(9):2017-2025. PubMed ID: 34056754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [123I]FP-CIT striatal binding in early Parkinson's disease patients with tremor vs. akinetic-rigid onset.
    Isaias IU; Benti R; Cilia R; Canesi M; Marotta G; Gerundini P; Pezzoli G; Antonini A
    Neuroreport; 2007 Sep; 18(14):1499-502. PubMed ID: 17712282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A 62-year-old man with familial parkinsonism with the onset at 24 years of the age].
    Takubo H; Kondo T; Mori H; Miyake T; Suda K; Yokochi M; Imai H; Mizuno Y
    No To Shinkei; 1996 Jun; 48(6):587-97. PubMed ID: 8703564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.